Hazlett, Burt & Watson’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Buy
3,450
+5
+0.1% +$1.78K 0.38% 66
2025
Q4
$1.13M Buy
3,445
+42
+1% +$13.3K 0.36% 66
2025
Q3
$956K Buy
3,403
+122
+4% +$35.4K 0.34% 70
2025
Q2
$917K Buy
3,281
+92
+3% +$26.1K 0.38% 62
2025
Q1
$992K Sell
3,189
-8
-0.3% -$2.36K 0.45% 54
2024
Q4
$835K Buy
3,197
+12
+0.4% +$3.56K 0.37% 65
2024
Q3
$1.02M Sell
3,185
-68
-2% -$22.2K 0.47% 48
2024
Q2
$1.01M Buy
3,253
+50
+2% +$14.7K 0.52% 42
2024
Q1
$911K Buy
3,203
+21
+0.7% +$6.14K 0.55% 39
2023
Q4
$914K Sell
3,182
-70
-2% -$19.1K 0.62% 31
2023
Q3
$874K Buy
3,252
+197
+6% +$49.2K 0.65% 26
2023
Q2
$678K Buy
3,055
+1
+0% +$232 0.51% 32
2023
Q1
$737K Buy
3,054
+1
+0% +$245 0.6% 30
2022
Q4
$800K Buy
3,053
+2
+0.1% +$536 0.7% 26
2022
Q3
$689K Sell
3,051
-10
-0.3% -$2.42K 0.67% 31
2022
Q2
$741K Sell
3,061
-26
-0.8% -$6.37K 0.68% 31
2022
Q1
$745K Buy
+3,087
New +$709K 0.59% 37

Other funds holding AMGN

Hazlett, Burt & Watson's AMGN Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its Amgen (AMGN) stake by 0.15% in Q1 2026, buying an estimated $1.78K and bringing the position to 3,450 shares worth $1.21M. The position accounts for 0.38% of the portfolio, ranked #66.

Hazlett, Burt & Watson first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hazlett, Burt & Watson held 3,450 shares of Amgen worth $1.21M as of Q1 2026.
  • Hazlett, Burt & Watson bought 5 Amgen shares in Q1 2026, an estimated $1.78K.
  • Amgen made up 0.38% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #66 holding.
  • Hazlett, Burt & Watson first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.